Fintel on MSN18h
William Blair Downgrades Incyte (INCY)Fintel reports that on March 18, 2025, William Blair downgraded their outlook for Incyte (NasdaqGS:INCY) from Outperform to Market Perform. Analyst Price Forecast Suggests 28.39% Upside As of March 4, ...
Jones Financial Companies Lllp bought a new position in shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report) ...
Jones Financial Companies Lllp increased its holdings in shares of AppFolio, Inc. (NASDAQ:APPF – Free Report) by 60.4% in the ...
Overall, Palantir has had a solid start to 2025. Its growth numbers look impressive, and its AI platform is gaining traction across industries. Yet not everyone is convinced. Some ...
Investor's Business Daily on MSN10h
Sarepta's 27% Sell-Off Is 'Overblown,' 'Overdone' And 'Overly Bearish.' Here's Why It Happened.Sarepta stock crashed Tuesday after a patient who received its approved gene therapy, Elevidys, died due to acute liver failure.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback